CNMD 8-K SEC Filing Analysis

Latest settled — T+5d

CNMD ▲ +1.47% at T+5d

NEUTRAL call ✓ call won +1.47% · α vs SPY +4.22% · entry $34.65 → $35.16

Next anchor: T+20d in 17d

Currently $34.77 · +0.35% from $34.65 entry

Entry anchored
Jun 1, 06:25 AM ET
via Databento tick

T+1d

-2.31%

call -2.31% · α -2.45%

$33.85

settled 11d ago

T+5d

+1.47%

call +1.47% · α +4.22%

$35.16

settled 5d ago

T+20d

—

call — · α —

—

in 17d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

CONMED entered into a $450 million incremental senior secured delayed draw term loan facility (Term A-2) to repurchase a portion of its outstanding 2.25% Convertible Senior Notes due 2026. The new facility matures June 10, 2030, carries initial interest margins of SOFR+1.75% or base+0.75%, and is secured by the same collateral and guarantees as the existing credit agreement. This restructuring addresses near-term convertible note maturities but adds substantial leverage to the balance sheet.

Key Financial Metrics

Deal Value

$450.0M

Actionable Insight

Refinancing reduces near-term convertible note maturity overhang but materially increases secured debt and leverage. Watch the Term A-2 borrowing draw timing — if drawn quickly, it signals urgency on the convertible repurchase. Monitor upcoming Q2 2026 earnings for leverage ratio and the CEO/CFO transition narrative given the recent executive departure.

Key Facts

$450M incremental senior secured delayed draw Term A-2 loan facility committed
Proceeds to repurchase portions of $800M 2.25% Convertible Senior Notes due 2026 (early maturing debt)
Term A-2 facility matures June 10, 2030, matching existing facility maturity
Interest margins: SOFR+1.75% / base+0.75% initially, ratcheting with leverage (1.125%-2.25% SOFR)
Borrowing availability window through June 14, 2026 (single drawing)
Cross-filing context: executive departure (5.02) filed 12 days prior, which in combination with a material agreement suggests forced management transition per significance note

Financial Impact

$450M incremental senior secured debt added to repurchase up to $800M of 2.25% convertible notes due 2026. Interest cost on new facility ranges from ~1.875% to 3.00% all-in (SOFR+spread). Leverage increases meaningfully but near-term convertible maturity risk is reduced.

leveragedebtinterest expensedilution

Risk Factors

Pro forma leverage will increase as $450M of new secured debt is added while the convertible notes are partially extinguished — net debt likely rises
The cross-filing executive departure within 12 days of this material agreement may signal forced management transition
Interest expense will increase significantly given the ~1.75% margin on the new facility vs the 2.25% convertible coupon — but the debt is secured rather than unsecured

Market Snapshot

Exchange

NYSE

Sector

Electromedical & Electrotherapeutic Apparatus

Analyst Consensus

0% bullish (11 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0002077096-26-000190
Document: ea0292464-8k_conmed.htm	0002077096-26-000190
Document: 0002077096-26-000190-index-headers.html	0002077096-26-000190
Document: 0002077096-26-000190-index.html	0002077096-26-000190
Document: 0002077096-26-000190.txt	0002077096-26-000190

3 reports for CNMD

T+1T+5T+20T+60

Filters

Reports for CNMD — sortable, filterable
	Type				Now
Jun 1, 2026 11d ago	8-K MIXED ★ 6/10	$34.65 $35.16	▲ +1.47%	▲ +4.22%	$34.77 (+0.35%)
May 20, 2026 23d ago	8-K NEUTRAL ★ 3/10	$37.01 $35.48	▼ −4.13%	▼ −5.37%	$34.77 (−6.05%)
Apr 7, 2026 9w ago	DEFA14A NEUTRAL ★ 3/10	$34.54 $39.73	▲ +15.03%	▲ +9.70%	$34.77 (+0.67%)

US Market Status

Market Closed — Opens Mon (53h 15m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access